Refinement of risk assessment of dermally and intermittently exposed pesticide workers : a critique

The regulatory requirements for the registration of pesticides are mainly evolved from concern about dietary exposure and risk, i.e. chronic oral exposure. Pesticide workers, however, are predominantly exposed dermally and intermittently. The present critique provides suggestions for improvement of toxicity studies to refine the risk assessment of pesticide workers. In this respect it is considered of utmost importance that toxicity studies (either toxicokinetic or toxicodynamic) should be tuned towards the anticipated exposure scenario. Apart from suggestions for improvement of dermal toxicokinetic and dynamic studies, recommendations for further research and guidance are given, amongst which the request for information on the robustness of in vitro dermal absorption studies and guidance on how to use these data. With respect to the intermittent exposure of pesticide workers it is recognised that both information on the anticipated exposure scenario as well as knowledge on the effect of intermittent exposure on the toxicity are needed. From a toxicological point of view, the setting of more than one Acceptable Operator Exposure Level (AOEL), covering effects that may arise after different periods of exposure, as well as the development of more robust acute and short term studies are strongly recommended. © 2001 British Occupational Hygiene Society. Published by Elsevier Science Ltd. All rights reserved. Chemicals/CAS: Pesticide

Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol

The validity of in vitro and in vivo methods for the prediction of percutaneous penetration in humans was assessed using the fungicide ortho-phenylphenol (OPP) (log Po/w 3.28, MW 170.8, solubility in water 0.7 g/L). In vivo studies were performed in rats and human volunteers, applying the test compound to the dorsal skin and the volar aspect of the forearm, respectively. In vitro studies were performed using static diffusion cells with viable full-thickness skin membranes (rat and human), nonviable epidermal membranes (rat and human), and a perfused pig ear model. For the purpose of conducting in vitro/in vivo comparisons, standardized experimental conditions were used with respect to dose (120 μg OPP/cm2), vehicle (60% aqueous ethanol), and exposure duration (4 h). In human volunteers, the potentially absorbed dose (amount applied minus dislogded) was 105 μg/cm2, while approximately 27% of the applied dose was excreted with urine within 48 h. In rats these values were 67 μg/cm2 and 40%, respectively. In vitro methods accurately predicted human in vivo percutaneous absorption of OPP on the basis of the potential absorbed dose. With respect to the other parameters studied (amount systemically available, maximal flux), considerable differences were observed between the various in vitro models. In viable full-thickness skin membranes, the amount systemically available and the potentially absorbed dose correlated reasonably well with the human in vivo situation. In contrast the Kp/maximal flux considerably underestimated the human in vivo situation. Although epidermal membranes overestimated human in vivo data, the species differences observed in vivo were reflected correctly in this model. The data generated in the perfused pig ear model were generally intermediate between viable skin membranes and epidermal membranes. © 2002 Elsevier Science (USA)

Assessment factors for human health risk assessment : a discussion paper

The general goal of this discussion paper is to contribute toward the further harmonization of human health risk assessment. It first discusses the development of a formal, harmonized set of assessment factors. The status quo with regard to assessment factors is reviewed, that is, the type of factors to be identified, the range of values assigned, as well as the presence or absence of a scientific basis for these values. Options are presented for a set of default values and probabilistic distributions for assessment factors based on the state of the art. Methods of combining default values or probabilistic distributions of assessment factors are also described. Second, the effect parameter, the no-observed-adverse-effect level (NOAEL), is discussed. This NOAEL as selected from the toxicological database may be a poor substitute for the unknown, true no-adverse-effect level (NAEL). New developments are presented with respect to the estimation of the NAEL. The already widely discussed Benchmark Dose concept can be extended to obtain an uncertainty distribution of the Critical Effect Dose (CED). This CED distribution can be combined with estimated uncertainty distributions for assessment factors. In this way the full distribution of the Human Limit Value will be derived and not only a point estimate, whereas information on dose-response relations is taken into account. Finally, a strategy is proposed for implementation of the new developments into human health risk assessments

Finding maximal transcriptome differences between reprotoxic and non-reprotoxic phthalate responses in rat testis

Toxicogenomics and risk assessmen